Clinical Trial Update: Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

View source ↗

Summary

An intervention development study evaluating Attention and Interpretation Modification (AIM) for fear of cancer recurrence, sponsored by Memorial Sloan Ketterin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Rare Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Rare Cancer | Status: ACTIVE_NOT_RECRUITING